Michael Cardenas, MD
Radiation Oncology · Garden City, MINPI 1043639081
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations.
Across 66 payments — averaging $23.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beone Medicines USA, Inc.$171
- Merck$167
- Novartis$140
- Genentech USA, Inc.$131
- Novocure Inc.$115
- Legend Biotech USA Inc.$103
- plus $725 from 20 others
What the payments were for
- Food & beverage$1,552100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beone Medicines USA, Inc. | 8 | $171 |
| Merck | 7 | $167 |
| Novartis | 6 | $140 |
| Genentech USA, Inc. | 6 | $131 |
| Novocure Inc. | 3 | $115 |
| Legend Biotech USA Inc. | 4 | $103 |
| Karyopharm Therapeutics Inc. | 3 | $78 |
| Caris MPI, Inc. | 2 | $61 |
| Johnson & Johnson | 3 | $60 |
| Agios Pharmaceuticals, Inc. | 2 | $59 |
| Azurity Pharmaceuticals, Inc. | 3 | $56 |
| Boehringer Ingelheim | 2 | $46 |
| Geron Corporation | 1 | $39 |
| AstraZeneca(2 entities) | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $34 |
| AVEO Pharmaceuticals, Inc. | 2 | $33 |
| Eisai Inc. | 1 | $29 |
| Iovance Biotherapeutics, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| Pharmaessentia USA Corporation | 1 | $27 |
| Tersera Therapeutics LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Sobi, Inc | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
How this compares
$1,552 in reported general payments places this provider in the 75th percentile of 198 radiation oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Garden City
- Frank ViciniPontiac$231K
- Thomas BoikeClarkston$171K
- Farzan SiddiquiDetroit$72K
- Daniel WahlAnn Arbor$42K
- Daniel ChangAnn Arbor$38K
- Shruti JollyAnn Arbor$30K
- Brandon ManciniGrand Rapids$30K
- Alvaro MartinezFarmington Hills$24K
- James KaneAnn Arbor$19K
- M Salim SiddiquiDetroit$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.